New Science Ventures

VC · New York (United States)

VC

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

New Science Ventures (NSV) is a venture capital firm established in 2004, specializing in investments that leverage breakthrough science to create significant value. With over $900 million in assets under management, NSV focuses on companies in the life sciences and information technology sectors that utilize novel scientific approaches to address substantial market needs. The firm operates from its headquarters in Connecticut and maintains an office in London.

Investment Criteria

Other investors that have backed the same portfolio companies as New Science Ventures. Expand any entry to see the shared portfolio companies.

• Easton Capital Investment Group

  4 shared

  Shared portfolio companies

  • Achronix Semiconductor Corporation
  • Resolve Therapeutics, LLC
  • TigerConnect, Inc.
  • Trellis Bioscience LLC
• Alumni Ventures

  2 shared

  Shared portfolio companies

  • Phase Four, Inc.
  • Sagence AI Corporation
• BioGeneration Ventures

  2 shared

  Shared portfolio companies

  • Escalier Biosciences B.V.
  • NorthSea Therapeutics B.V.
• Green D Ventures

  2 shared

  Shared portfolio companies

  • Phase Four, Inc.
  • Sagence AI Corporation
• In-Q-Tel

  2 shared

  Shared portfolio companies

  • ABL Space Systems Company
  • Paragraf Limited
• IQ Capital Partners

  2 shared

  Shared portfolio companies

  • Myrtle Software Ltd
  • Paragraf Limited
• Khosla Ventures

  2 shared

  Shared portfolio companies

  • Glydways, Inc.
  • Sagence AI Corporation
• Martlet Capital

  2 shared

  Shared portfolio companies

  • Myrtle Software Ltd
  • Paragraf Limited
• 5Y Capital (Morningside Venture Capital)

  1 shared

  Shared portfolio companies

  • ProterixBio, Inc.
• 8VC

  1 shared

  Shared portfolio companies

  • DUST Identity, Inc.